|
시장보고서
상품코드
1964235
보조 지혈제 시장 규모, 점유율, 성장 분석 : 제품 유형별, 응용 분야별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Adjunctive Hemostats Market Size, Share, and Growth Analysis, By Product Type, By Application Area, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 보조 지혈제 시장 규모는 2024년에 8억 5,640만 달러로 평가되었고, 2025년 9억 1,977만 달러에서 2033년까지 16억 2,823만 달러로 성장할 전망입니다. 또한 예측 기간(2026-2033년) CAGR은 7.4%를 나타낼 것으로 예측됩니다.
세계 보조 지혈제 시장은 주로 수술의 복잡성과 효과적인 출혈 제어 솔루션에 대한 수요 증가에 의해 주도되고 있습니다. 이러한 지혈제(국소 도포제, 패치, 실란트 포함)는 특히 심혈관 수술 및 종양학 분야에서 복잡한 수술 중 비압박성 출혈을 관리하는 데 필수적입니다. 기술 혁신으로 기초 재료에서 고급 젤라틴 트롬빈 매트릭스 및 생물학적 실란트로 진화하여 그 효과와 안전성이 향상되었습니다. 무작위 시험과 실제 임상연구를 통해 출혈 합병증 감소와 수술 시간 단축을 입증한 근거가 병원에서의 조달을 더욱 촉진하고 있습니다. 또한, 제품 개발에 인공지능(AI)을 통합하여 재료 발견을 촉진하고, 외과 의사의 요구에 맞는 기능적 설계를 통해 설계 프로세스를 가속화하여 다양한 수술 환경에서 도입이 용이하고 상업적 기회를 창출할 수 있도록 지원합니다.
세계 보조 지혈제 시장 성장 촉진요인
세계 수술 건수가 증가함에 따라 보조 지혈제에 대한 수요가 크게 증가하고 있습니다. 의료 전문가와 수술팀은 신속한 지혈, 수술 중 출혈 최소화, 수술 전후 결과 개선을 위해 효과적인 도구가 필요하기 때문입니다. 복잡한 수술과 최소침습 수술의 확산으로 보조 지혈제의 임상적 이점이 널리 알려지면서 병원과 외과 의사들이 지혈제를 표준 치료법으로 채택하는 움직임이 가속화되고 있습니다. 이러한 광범위한 수용은 조달량 증가와 약품 리스트에 등재되어 일상적인 사용을 촉진합니다. 이를 통해 시장에서의 채택이 확대될 뿐만 아니라 제품 공급 체계와 유통망에 대한 지속적인 투자가 이루어지고 있습니다.
세계 보조 지혈제 시장 성장 억제요인
세계 보조 지혈제 시장은 특정 제품의 취득 비용 상승, 병원 내 구매 결정에 영향을 미치는 불일치한 상환 정책 등의 문제에 직면해 있습니다. 비용 중심의 의료 환경에서는 추가 제품 비용에 대한 지불자의 명확한 지원이 부족하기 때문에 조달 위원회는 저비용 대체품이나 표준적인 방법을 선호하는 경향이 있습니다. 이러한 소극적인 태도는 보조 지혈제의 빈번한 사용을 방해하고 임상 프로토콜에의 통합을 지연시키고 있습니다. 그 결과, 임상적 이점으로 인한 사용 확대 가능성에도 불구하고 반복 구매가 감소하고 시장 침투가 제한되어 시장 성장을 저해하고 있습니다.
세계 보조 지혈제 시장 동향
세계 보조 지혈제 시장은 최소침습 수술 기술의 보급 확대에 힘입어 큰 변화의 시기를 맞이하고 있습니다. 외과 수술이 발전함에 따라 제한된 환경에서 우수한 지혈 효과를 발휘하고 빠른 출혈 제어와 복잡한 해부학적 구조에 대한 적응성을 갖춘 지혈제에 대한 수요가 증가하고 있습니다. 이러한 추세는 얇고 유동적이며 분무 가능한 지혈제 개발을 촉진하고, 첨단 수술 기구와 원활하게 연동할 수 있는 전용 어플리케이터의 개발을 촉진하고 있습니다. 각 제조업체들은 외과 의사들의 요구에 부응하기 위해 제품 패키지 개선, 교육 솔루션 제공, 호환성 최적화를 진행하고 있습니다. 이를 통해 다양한 수술 전문 분야에서 보다 폭넓은 수용과 적용을 촉진할 것으로 예측됩니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 보조 지혈제 시장 규모 : 제품 유형별&CAGR(2026-2033)
세계의 보조 지혈제 시장 규모 : 응용 분야별&CAGR(2026-2033)
세계의 보조 지혈제 시장 규모 : 최종사용자별&CAGR(2026-2033)
세계의 보조 지혈제 시장 규모 : 유통 채널별&CAGR(2026-2033)
세계의 보조 지혈제 시장 규모&CAGR(2026-2033)
경쟁 정보
주요 기업 개요
결론과 제안
LSHGlobal Adjunctive Hemostats Market size was valued at USD 856.4 Million in 2024 and is poised to grow from USD 919.77 Million in 2025 to USD 1628.23 Million by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).
The Global Adjunctive Hemostats Market is primarily driven by the increasing complexity of surgical procedures and the growing demand for effective bleeding control solutions. These hemostatic agents, including topical applications, patches, and sealants, are crucial in managing non-compressible bleeding during intricate surgeries, particularly in cardiovascular and oncologic contexts. Innovations have evolved from basic materials to advanced gelatin-thrombin matrices and biological sealants, enhancing their efficacy and safety. Evidence from randomized trials and real-world studies showcasing reduced bleeding complications and shorter operation times further propel hospital procurement. Additionally, the integration of artificial intelligence (AI) in product development enhances material discovery and accelerates the design process by tailoring features to surgeon needs, ultimately facilitating easier adoption and commercial opportunities across diverse surgical settings.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adjunctive Hemostats market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Adjunctive Hemostats Market Segments Analysis
Global adjunctive hemostats market is segmented by product type, application area, end user, distribution channel and region. Based on product type, the market is segmented into Gel-based Hemostats, Foam-based Hemostats and Fiber-based Hemostats. Based on application area, the market is segmented into Surgical Procedures and Trauma Cases. Based on end user, the market is segmented into Hospitals, Ambulatory Surgery Centers and Clinics. Based on distribution channel, the market is segmented into Direct Sales, Online Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Adjunctive Hemostats Market
The growing volume of surgical procedures worldwide significantly boosts the demand for adjunctive hemostats, as healthcare professionals and surgical teams require effective tools to attain swift hemostasis, minimize intraoperative bleeding, and enhance overall perioperative results. With the increasing prevalence of complex and minimally invasive surgeries, the clinical advantages of adjunctive hemostats are becoming more recognized, prompting hospitals and surgeons to adopt these products into standard care practices. This widespread acceptance leads to greater procurement and formulary inclusion, resulting in routine usage that not only broadens market adoption but also encourages ongoing investment in product availability and distribution networks.
Restraints in the Global Adjunctive Hemostats Market
The Global Adjunctive Hemostats market faces challenges due to elevated acquisition costs for specific products and inconsistent reimbursement policies that affect purchasing decisions within hospitals. In cost-sensitive healthcare environments, lack of clear support from payers for additional product expenses leads procurement committees to favor lower-cost alternatives or standard practices. This reluctance hinders the frequent use of adjunctive hemostats and slows their integration into clinical protocols. Consequently, the market growth is impeded as repeat purchases wane and broader market penetration is restricted, despite the potential clinical benefits that could drive increased utilization.
Market Trends of the Global Adjunctive Hemostats Market
The Global Adjunctive Hemostats market is experiencing a significant shift driven by the increasing adoption of minimally invasive surgical techniques. As surgical practices evolve, there is a growing demand for hemostatic agents that excel in constrained environments, offering rapid bleeding control and the ability to adapt to complex anatomical structures. This trend is propelling the development of low-profile, flowable, and sprayable hemostats, along with specialized applicators designed for seamless integration with advanced surgical instruments. Manufacturers are enhancing product packaging, providing training solutions, and optimizing compatibility to align with surgeon preferences, ultimately facilitating broader acceptance and application across diverse surgical specialties.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Adjunctive Hemostats Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Gel-based Hemostats
- Foam-based Hemostats
- Fiber-based Hemostats
Global Adjunctive Hemostats Market Size by Application Area & CAGR (2026-2033)
- Market Overview
- Surgical Procedures
- Orthopedic Surgeries
- Cardiovascular Surgeries
- Trauma Cases
Global Adjunctive Hemostats Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Ambulatory Surgery Centers
- Clinics
Global Adjunctive Hemostats Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct Sales
- Online Sales
- Distributors
Global Adjunctive Hemostats Market Size & CAGR (2026-2033)
- North America (Product Type, Application Area, End User, Distribution Channel)
- US
- Canada
- Europe (Product Type, Application Area, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application Area, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application Area, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application Area, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- C.R. Bard
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ethicon
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ZymoGenetics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hemostasis LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Anika Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Acelity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tissuemed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CryoLife
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Plexus Biomedical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biometrix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cohera Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Revive Surgical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Haemostatic Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arthrex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sientra
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
